Significance of close surveillance of patients with peripheral arterial disease

Angiology

Volumn 60, Issue 4, 2009, Pages 462-467

  Barrows, Robin Joyce ^a   Krumsdorf, Ulrike ^a   Zankl, Alexandra ^a   Katus, Hugo ^a   Tiefenbacher, Christiane Pia ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b MARIEN HOSPITAL WESEL   (Germany)

Author keywords

Cardiovascular disease; Peripheral arterial disease; Secondary prevention

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; CARDIOVASCULAR AGENT;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; COMORBIDITY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG USE; FEMALE; GENERAL PRACTITIONER; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PAIN; PERIPHERAL VASCULAR DISEASE; PREVALENCE; SECONDARY PREVENTION; SMOKING; WALKING; ANKLE; BLOOD PRESSURE; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CONVALESCENCE; DISEASE COURSE; DRUG COMBINATION; KAPLAN MEIER METHOD; MORTALITY; PATHOPHYSIOLOGY; RISK ASSESSMENT; RISK FACTOR; TIME; TREATMENT OUTCOME; VASCULARIZATION;

AGED; ANKLE; BLOOD PRESSURE; BRACHIAL ARTERY; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; COMORBIDITY; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; PERIPHERAL VASCULAR DISEASES; RECOVERY OF FUNCTION; RISK ASSESSMENT; RISK FACTORS; SECONDARY PREVENTION; TIME FACTORS; TREATMENT OUTCOME; WALKING;

EID: 70349560850     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319708322923     Document Type: Article

References (27)

1. Cheng A., Braunstein JB, Dennison C., Nass C., Blumenthal RS Reducing global risk for cardiovascular disease: using lifestyle changes and pharmacotherapy. Clin Cardiol. 2002 ; 25: 205-212.
2. getABI Study group. getABI: German epidemiological trial on ankle brachial index for elderly patients in family practice to detect peripheral arterial disease, significant marker for high mortality. Vasa. 2002 ; 31: 241-248.
3. Criqui MH Peripheral arterial disease: epidemiological aspects. Vasc Med. 2001 ; 6: 3-7.
4. Kannel WB, McGee DL Update on some epidemiologic features of intermittent claudication: the Framingham Study. J Am Geriatr Soc. 1985 ; 33: 13-18.
5. Bhatt DL, Steg PG, Ohman EM, et al. for the REACH Registry Investigators. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006 ; 295: 180-189.
6. Criqui MH, Denenberg JO, Langer RD, Fronek A. The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med. 1997 ; 2: 221-226.
7. Valentine RJ, Guerra R., Stephan P., Scoggins E., Clagett GP, Cohen J. Family history is a major determinant of subclinical peripheral arterial disease in young adults. J Vasc Surg. 2004 ; 39: 351-356.
8. Mukherjee D., Lingam P., Chetcuti S., et al. Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions: insights from the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2. Circulation. 2002 ; 106: 1909-1912.
9. Dormandy J., Heeck L., Vig S. Predictors of early disease in the lower limbs. Semin Vasc Surg. 1999 ; 12: 109-117.
10. Oĝ€™Hare A., Johansen K. Lower-extremity peripheral arterial disease among patients with end-stage renal disease. J Am Soc Nephrol. 2001 ; 12: 2838-2847.
11. Daskalopoulou S., Pathmarajah M., Kakkos S., et al. Association between ankle-brachial index and risk factor profile in patients newly diagnosed with intermittent claudication. Circ J. 2008 ; 72: 441-448.
12. Langlois M., De Bacquer D., Duprez D., De Buyzere M., Delanghe J., Blaton V. Serum uric acid in hypertensive patients with and without peripheral arterial disease. Atherosclerosis. 2003 ; 168: 163-168.
13. Schainfeld RM Management of peripheral arterial disease and intermittent claudication. J Am Board Fam Pract. 2001 ; 14: 443-450.
14. Palmer-Kazen U., Wahlberg E. Arteriogenesis in peripheral arterial disease. Endothelium. 2003 ; 10: 225-232.
15. Smith SC Jr, Blair SN, Criqui MH, et al. Preventing heart attack and death in patients with coronary disease. Circulation. 1995 ; 92: 2-4.
16. Antiplatelet Trialistsĝ€™ Collaboration. Collaborative overview of randomized trials of antiplatelet therapy. Prevention of death, myocardial infaction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ. 1994 ; 308: 81-106.
17. Deutsche Gesellschaft f?1/4r Angiologie (DGA), Gesellschaft f?1/4r Gef?Currency signmedizin. Leitlinien zur diagnostik und therapie der arteriellen verschlusskrankheit der becken-beinarterien. Vasa. 2001 ; 30: 15-16.
18. Macovei L. Pleiotropic effects of therapy in endothelial dysfunction syndrome [in Romanian]. Rev Med Cir Soc Med Nat Iasi. 2004 ; 108: 17-22.
19. Bismuth J., Kofoed SC, Sillesen HH Lipid-lowering treatment of patients with atherosclerotic disease of the lower extremities [in Danish]. Ugeskr Laeger. 2001 ; 163: 6882-6885.
20. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo-controlled trial. Lancet. 2002 ; 360: 7-22.
21. Grobbee DE, Bots ML Statin treatment and progression of atherosclerotic plaque burden. Drugs. 2003 ; 63: 893-911.
22. Aung PP, Maxwell HG, Jepson RG, Price JF, Leng GC Lipid-lowering for peripheral arterial disease of the lower limb. Cochrane Database Syst Rev. 2007 ; 4: CD000123.
23. Hirsch AT, Criqui MH, Treat-Jacobson D., et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001 ; 286: 1317-1324.
24. Buitron-Granados LV, Martinez-Lopez C., Escobedo-de la Pena J. Prevalence of peripheral arterial disease and related risk factors in an urban Mexican population. Angiology. 2004 ; 55: 43-51.
25. TransAtlantic Inter-Society Consensus (TASC). Management of peripheral arterial disease (PAD). J Vasc Surg. 2000 ; 31: S5 - S14, S93 - S101.
26. Diehm C., Lange S., von Stritzky B., et al. Eine zunehmende zahl der risikofaktoren ?Currency signlterer patienten ist mit einer erh?¶hten pr?Currency signvalenz der peripheren arteriellen verschlusskrankheit und mit erh?¶hter mortalit?Currency signt verkn?1/4pft. Med Klin (Munich). 2004 ; 99: 166.
27. Diehm C., Schuster A., Allenberg JR, et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis. 2004 ; 172: 95-105. (Pubitemid 38058606)